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Abstract
A 59 year old man underwent mechanical tricuspid valve replacement and removal of pacemaker
generator along with 4 pacemaker leads for pacemaker endocarditis and superior vena cava
obstruction after an earlier percutaneous extraction had to be abandoned, 13 years ago, due to
cardiac arrest, accompanied by silent, unsuspected right atrial perforation and exteriorisation of
lead. Postoperative course was complicated by tricuspid valve thrombosis and secondary
pulmonary embolism requiring TPA thrombolysis which was instantly successful. A review of
literature of pacemaker endocarditis and tricuspid thrombosis along with the relevant management
strategies is presented. We believe this case report is unusual on account of non operative
management of right atrial lead perforation following an unsuccessful attempt at percutaneous
removal of right sided infected pacemaker leads and the incidental discovery of the perforated lead
13 years later at sternotomy, presentation of pacemaker endocarditis with a massive load of
vegetations along the entire pacemaker lead tract in superior vena cava, right atrial endocardium,
tricuspid valve and right ventricular endocardium, leading to a functional and structural SVC
obstruction, requirement of an unusually large dose of warfarin postoperatively occasioned, in all
probability, by antibiotic drug interactions, presentation of tricuspid prosthetic valve thrombosis
uniquely as vasovagal syncope and isolated hypoxia and near instantaneous resolution of tricuspid
prosthetic valve thrombosis with Alteplase thrombolysis.
Case presentation
A 40 year old man underwent dual chamber right infracla-
vicular pacemaker implantation for malignant vasovagal
syndrome in 1988. This was complicated by two further
reexplorations, one for a slipped atrial lead, and the sec-
ond for primary wound dehiscence which required a
pulse generator change. This was followed, in 1993, by
infection of the pacemaker pocket by Staphylococcus epi-
dermidis requiring pacemaker removal. However, only
the pulse generator could be removed, and the percutane-
ous removal of the leads by traction had to be abandoned
on account of cardiac arrest, in all probability, and with
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the benefit of hindsight, due to perforation of right atrium
by the atrial lead during attempted percutaneous removal
which consequently had to be abandoned. The patient
was resuscitated successfully without taking recourse to
median sternotomy, the leads were cut short and buried
under pectoralis major and the wound closed. A fresh
dual chamber pacemaker was implanted in left infracla-
vicular pocket, followed by an elective pulse generator
change in 2001. Patient next presented in December 2006
with history of fever, rigors, night sweats and weight loss.
Examination revealed bilateral pacemaker pocket infec-
tion and discharge and unremarkable cardiovascular
examination. Chest X ray confirmed four pacing leads in
the SVC, with two in right atrium and two in right ventri-
cle, a pulse generator in the left infraclavicular pocket only
(fig 1). Routine blood examination revealed white cell
count of 20.3, neutrophils 17.3 and CRP 59. Bacterial cul-
ture of the wound discharge grew coagulase negative sta-
phylococcus. Intravenous vancomycin and gentamycin
was started. Vancomycin was changed to intravenous flu-
cloxacillin after two days and oral rifampicin added sub-
sequently. Transthoracic echocardiogram demonstrated
large vegetations associated with the pacing leads at the
atrial level, part of which prolapsed through the tricuspid
valve during diastole (fig 2). Transesophageal echocardio-
gram revealed extensive and complex vegetation sur-
rounding all leads in SVC, RA, RV and also involving
tricuspid valve and right atrial and right ventricular endo-
cardium (fig 3). At median sternotomy, one of the atrial
leads was densely adherent to the under surface of the
right half of the sternum just below the manubriosternal
joint. It was surrounded by a large fibrous granuloma
from the point it exited from the atrium till the point of its
adherence to the under surface of the sternum (figs 4, 5).
Presumably, the lead perforated the right atrium during
the attempted percutaneous removal of the right sided
pacing leads in 1993 which had to be abandoned when
patient had had an asystolic arrest. Pericardial cavity was
obliterated by adhesions. Cardiopulmonary bypass was
established with ascending aortic and direct SVC and IVC
cannulations. Caval tapes were snugged, temperature was
allowed to only gently drift and right atriotomy was made
on the beating heart. Both infraclavicular pacemaker
pockets were exposed and the pulse generator on the left
side removed after disconnecting the leads. The perforated
Chest X ray (PA) showing 2 atrial and 2 ventricular pacing  leads and 1 pulse generator in left infraclavicular pocket, the  right sided pulse generator having been removed previously Figure 1
Chest X ray (PA) showing 2 atrial and 2 ventricular 
pacing leads and 1 pulse generator in left infraclavicu-
lar pocket, the right sided pulse generator having 
been removed previously.
Transthoracic echocardiogram showing a large right atrial  vegetation Figure 2
Transthoracic echocardiogram showing a large right 
atrial vegetation.
Transthoracic echocardiogram showing vegetations in rela- tion to the endocardial pacing lead Figure 3
Transthoracic echocardiogram showing vegetations 
in relation to the endocardial pacing lead.Journal of Cardiothoracic Surgery 2009, 4:12 http://www.cardiothoracicsurgery.org/content/4/1/12
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atrial lead lying under the sternum, encased in the pericar-
dial granuloma, was dissected out within the granuloma,
excised at the level of the appendage and removed (figs 6,
7). The remaining portion of the lead, along with the
other atrial lead, were removed after dissecting them out
from the atrial endocardium along with the adherent
thrombotic vegetations. There were large vegetations on
the posterior and septal leaflets tricuspid valve leaflets and
the chordae of the two leaflets had twined themselves
around the ventricular pacing leads (fig 8). The endocar-
dium of the inlet of the right ventricle was infiltrated by
vegetations as well. The ventricular pacing leads were dis-
sected off from the ventricular muscle and the tricuspid
valve leaflets and chordae and removed. The tricuspid
valve leaflets were excised completely, the adjoining atrial
and ventricular infiltrated endocardium debrided and a
31 mm St Jude mechanical prosthesis stitched in place
using 14 pledgetted interrupted 2 O ticron sutures. Atriot-
omy closed in a single layer. An epicardial pacemaker
(Medtronic) was sutured in place and the pulse generator
kept in a preperitoneal and retrorectus position in left
hypochondrium and set at a rate of 90/min. Post proce-
dure TOE revealed satisfactory prosthetic valve function
and no residual vegetations in SVC, RA or RV. Patient
received intravenous Flucloxacillin and oral rifampicin for
a total duration of 6 weeks. Post operative period was
uncomplicated apart from the requirement for large doses
of warfarin to maintain INR in the required range, possi-
bly as a result of antibiotic interactions. The postoperative
transthoracic echocardiogram showed satisfactory tricus-
pid prosthetic valve function and patient was discharged
home, 5 weeks after his operation.
He represented two weeks later with syncope while blood
was being withdrawn for INR estimation. Examination
revealed profound hypoxia with 88% oxygen saturations,
no audible metallic heart sounds and 2 cm hepatomegaly.
Arterial blood gas revealed pH 7.52, pO2 5.69, pCO2
3.64, HCO3 24.7. INR was suboptimal at 1.9. Transtho-
racic echocardiogram revealed antegrade flow across tri-
cuspid prosthesis increased at 2.5 m/sec, prolonged
pressure half time of 270 msec (fig 9) and an estimated
effective tricuspid prosthetic orifice area of 0.8 cm2. No
obvious valve occluder excursion, in contrast to the imme-
diate postoperative echo, was seen and a small amount of
mobile friable material was visualised on the ventricular
side of the valve). Tricuspid valve fluoroscopy confirmed
restricted occluder excursion. The right atrium was dilated
with bulging of interatrial septum. Both ventricles were
contracting well. A contrast CT angiogram of pulmonary
arteries demonstrated a "wispy", ill defined embolus in
left pulmonary artery extending into upper lobar artery
which could have been chronic (fig 10). There was also
Intraoperative photograph showing the tip of a pacemaker  lead lying outside the right atrium, surrounded by inflamma- tory granuloma and densely adherent to the undersurface of  the sternum Figure 4
Intraoperative photograph showing the tip of a pace-
maker lead lying outside the right atrium, sur-
rounded by inflammatory granuloma and densely 
adherent to the undersurface of the sternum.
Intraoperative photograph showing the extra pericardial  location of the lead Figure 5
Intraoperative photograph showing the extra peri-
cardial location of the lead.Journal of Cardiothoracic Surgery 2009, 4:12 http://www.cardiothoracicsurgery.org/content/4/1/12
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evidence of extensive backfilling of the azygous system
from the superior vena cava (fig 11), with some degree of
residual stenosis both at the confluence of innominate
veins and also at the junction of SVC with right atrium (fig
12). A diagnosis of tricuspid prosthetic thrombosis was
made. Whether there was recent or old embolisation into
PA was difficult to establish with certainty. Since the
patient was haemodynamically stable and since his oxy-
genation improved somewhat with increasing the
inspired oxygen concentration, it was elected to, in the
first instant, to treat with aggressive anticoagulation with
intravenous heparin and oral warfarin, aiming to keep
both INR and APTT between 3.5 to 4.5. One week later,
however, TOE continued to show significant prosthetic
thrombotic obstruction with no clinical improvement.
Patient was, therefore, thrombolysed with100 mgs of
Alteplase given as a standard 3 hr infusion. Patient felt
symptomatic improvement instantaneously, with oxygen
saturations improving to 97% and later 100%, restoration
of normal pulmonary gaseous exchange. Transthoracic
echo showed no gradient across the tricuspid prosthesis,
with normal pressure half time (fig 13). Fluoroscopy con-
firmed restoration of normal prosthetic leaflet excursions.
Patient was discharged home, 2 weeks after his readmis-
sion, requiring 12 mgs of warfarin to keep his INR
between 3.5 and 4.5. Patient is being followed up regu-
larly in outpatient clinic and continues in NYHA class1
and has resumed all previous activities.
Discussion
Pacemaker system infections can be generator pocket or
lead infections and complicate 0.5 – 2 percent permanent
pacemaker implantations [1]. The usual predisposing
causes of infection include haematoma, erosion, long
duration of procedure, operator's inexperience and reex-
ploration [2]. Early infections are most commonly caused
by staphylococcus aureus and late infections most com-
Intraoperative photograph showing the inflammatory granu- loma having been dissected to reveal the tip of the pace- maker lead Figure 6
Intraoperative photograph showing the inflamma-
tory granuloma having been dissected to reveal the 
tip of the pacemaker lead.
Intraoperative photograph showing the tip of the pacemaker  lead in greater detail Figure 7
Intraoperative photograph showing the tip of the 
pacemaker lead in greater detail.Journal of Cardiothoracic Surgery 2009, 4:12 http://www.cardiothoracicsurgery.org/content/4/1/12
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monly by staphylococcus epidermidis, although infec-
tions by staphylococcus lugudensis [3] streptococcus
bovis, mitis and sanguis, pseudomonas [4], enterococci
and fungi and even Mycobacterium fortuitum [5] have
been described. Pacemaker infections present as local dis-
charge, inflammation or abscess, erosion of part of the
pacemaker system with secondary infection, or, more
rarely, with endocarditis, sepsis and positive blood cul-
tures. Pacemaker endocarditis refers to the presence of
infective material in relation to the pacemaker system, in
the veins leading up to the heart, or the chambers or the
valves of the right heart. Pacemaker endocarditis is most
commonly complicated by tricuspid valve vegetations [6],
tricuspid regurgitation and occasionally by secondary pul-
monary embolism [7]. Rare complications include SVC
Intraoperative photograph showing the right ventricular  pacemaker lead surrounded by vegetations Figure 8
Intraoperative photograph showing the right ven-
tricular pacemaker lead surrounded by vegetations.
Doppler echocardiogram showing a prolonged pressure half  time of 270 msec suggestive of severe prosthetic tricuspid  obstruction Figure 9
Doppler echocardiogram showing a prolonged pres-
sure half time of 270 msec suggestive of severe pros-
thetic tricuspid obstruction.
Contrast CT angiogram of left pulmonary artery showing a  "wispy" ill defined embolus in the upper lobar artery Figure 10
Contrast CT angiogram of left pulmonary artery 
showing a "wispy" ill defined embolus in the upper 
lobar artery.
Contrast CT angiogram showing extensive backfilling of  azygous system from superior vena cava Figure 11
Contrast CT angiogram showing extensive backfill-
ing of azygous system from superior vena cava.Journal of Cardiothoracic Surgery 2009, 4:12 http://www.cardiothoracicsurgery.org/content/4/1/12
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thrombosis [8] tricuspid stenosis [9] and paradoxical
emboli [10].
Our patient presented 18 years subsequent to his first
pacemaker implantation with bilateral pacemaker pocket
and lead infection with staphylococcus epidermidis, com-
plicated by tricuspid valve and right ventricular endocar-
ditis and further complicated by SVC obstruction due to
partly the sheer load of huge vegetations surrounding the
4 pacemaker leads in the SVC and partly by the stenotic
changes in the vena cava as evidenced by the extensive
backfilling of the azygous system on the contrast CT. The
infection of the pacemaker pocket and the lead and the
subsequent endocarditis could have been predicted on the
basis of previous three reexplorations on the right side,
one for slipped lead, the second for erosion and the last
for unsuccessful percutaneous lead extraction, and one on
the left side for elective pulse generator change.
There is general consensus that once there is pacemaker
pocket or lead infection, removal of the whole pacemaker
system followed by a course of appropriate antibiotics
results in the best prospect for long term eradication of
infection [11-14,7]. When pacemaker lead or pocket
infection is complicated by vegetations on the leads, heart
valves or chamber endocardium or when there is second-
ary pulmonary embolism, removal of the entire device is
more urgently indicated. Pacemaker leads can be extracted
percutaneously or after median sternotomy with cardiop-
ulmonary bypass. Percutaneous extraction is preferably
done under TOE guidance when there are no complicat-
ing factors like vegetations or endocarditis. Percutaneous
lead extraction has been advanced by techniques initially
described by Byrd [15,16] and perfected by other opera-
tors later [12,17,18]. The technique essentially involves
counter traction to the myocardium by a plastic sheath
passed over the lead while traction is applied to the lead
tip by a stylet which passes to the tip of the lead through
a central channel in it and which locks it by uncoiling it.
Percutaneous extraction can fail, or may be complicated
by non fatal pulmonary embolism [19], avulsion of tri-
cuspid valve leaflet [18] or lead tip fracture with resulting
vegetation [20]. TOE has been of value not only to diag-
nose the above complications, with the exception of PE,
before the patient leaves the catheterization lab, but also
to guide the mode of pacemaker lead removal. Generally
lead removal by percutaneous traction in the presence of
vegetations less than 1 cm is considered relatively safe,
although one study described successful percutaneous
traction in 9 out of 12 patients, with vegetations larger
than 1 cm, with pacemaker endocarditis, with no post
procedure secondary pulmonary embolism [21]. Authors
of one study of 53 patients with pacemaker endocarditis,
out of which 29 had transvenous extraction with locking
stylets and sheaths, reported one surgical conversion, no
tamponade and no major pulmonary embolism. They
recommended that those patients who have vegetations
that might obstruct main pulmonary artery should have
removal under cardiopulmonary bypass [12].
As a general rule, however, in pacemaker endocarditis
complicated by lead, tricuspid valve or RA or RV vegeta-
Contrast CT angiogram showing residual stenosis both at the  confluence of the two innominate veins and at the junction of  SVC with right atrium Figure 12
Contrast CT angiogram showing residual stenosis 
both at the confluence of the two innominate veins 
and at the junction of SVC with right atrium.
Post thrombolysis Doppler echocardiogram showing com- plete resolution of tricuspid prosthetic thrombus as sug- gested by a normal pressure half time Figure 13
Post thrombolysis Doppler echocardiogram showing 
complete resolution of tricuspid prosthetic thrombus 
as suggested by a normal pressure half time.Journal of Cardiothoracic Surgery 2009, 4:12 http://www.cardiothoracicsurgery.org/content/4/1/12
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tions, removal of pacemaker leads is best done through
median sternotomy, employing cardiopulmonary bypass
and debriding the right heart chambers and the tricuspid
valve, under direct vision, of the infected vegetations and
debris. This offers the best method of achieving long term
eradication of infection from the chambers of heart.
Although removal of infected pacemaker system without
employing cardiopulmonary bypass, under inflow occlu-
sion, has been described [22], the authors would not
advocate this procedure except under exceptional circum-
stances. However, the author (PK) has removed a stuck
right ventricular lead, in a different patient, through a
purse string in the right atrial appendage, without taking
recourse to cardiopulmonary bypass, in the absence of
lead, chamber or valve vegetations, and with TOE moni-
toring. There has been one report of removal of a pace-
maker lead sticking out of right atrium without
cardiopulmonary bypass by using a purse string around
the projecting lead [23].
Pacemaker endocarditis only rarely involves the tricuspid
valve to the extent of destroying it and mostly debride-
ment of vegetations from the valve and preservation of the
valve itself suffices. However, occasionally excision of the
tricuspid valve with or without valve replacement [24], tri-
cuspid valve reconstruction with PTFE chordae [25] and
balloon dilatation 4 years after pacemaker endocarditic
tricuspid stenosis [9] have been described. Taira reported
tricuspid valve stenosis related to subvalvar adhesion of a
non infected loop of an excessively long ventricular lead
[26] and Hagers reported acquired tricuspid stenosis in a
patient with recurrent pacemaker lead endocarditis, fur-
ther complicated by a paradoxical septic embolism
through a PFO [10]. Surgery for pacemaker endocarditis
may be accompanied by additional procedures [14] apart
from tricuspid valve surgery, including pulmonary
embolectomy [27]. Hong et al described removal of 6
entrapped endocardial pacemaker leads with concomitant
redo coronary artery bypass grafting [28].
Lead perforation during implantation is a recognised but
rare complication of transvenous pacemaker implanta-
tion. It may present by a rising stimulation threshold, an
RBBB pattern from an RV lead, intercostal muscle or dia-
phragmatic contraction, friction rub after implantation,
pericarditis, pericardial effusion, cardiac tamponade or
rarely, no symptoms [1].
It was only at median sternotomy after dissecting the large
granulomatous mass found adherent to the under surface
of the sternum near the manubrium that it was realised
that there had been a perforation of the right atrium with
one of the right atrial leads, the lead having exited the
right atrial appendage, and then migrated a considerable
distance to lie adherent to the under surface of the ster-
num. This could only have happened at the time of the
previous unsuccessful attempt at percutaneous extraction
of the pacemaker leads which had been complicated by
cardiac arrest after which the extraction was abandoned
and a new pacemaker system implanted from the left side.
Since these leads were not connected to the pulse genera-
tor which had been removed, the lead would have got fur-
ther exteriorised with cardiac contractions without at the
same time giving rise to frank bleeding into pericardial
cavity. Obliteration of pericardial cavity by adhesions at
sternotomy confirms this presumed course of events.
Presence of huge vegetations along the entire tract of the
leads including right atrial and right ventricular endocar-
dium and the tricuspid valve as well as the entangling of
the tricuspid valve chordae with the RV leads mandated
excision and replacement of tricuspid valve with a pros-
thetic valve.
There has been a tremendous improvement in prosthetic
valve thrombosis in tricuspid position since Thorburn
reported 20% incidence in monoleaflet models [29]. Sub-
sequent reports, corresponding to a mixture of newer
valve models, showed incidence lower than 0.7% per
patient year [30,31]. Presentation may include fatigue,
syncope, distended neck veins, signs of fluid retention,
muffled valve clicks and middiastolic or pansystolic mur-
murs in tricuspid area. Confirmation by TTE requires pres-
ence of the following criteria: 1) high transvalvular
gradients – mean of 6 mm Hg or higher, and peak of 15
mm Hg or higher 2) transvalvular gradients 50% or higher
than observed before 3) visible thrombus on the pros-
thetic valve 4) inability to demonstrate 2 different mobile
echoes representing the valve leaflets in a high quality
image. Inability of the valve leaflets to either fully open or
close on fluoroscopy employing multiple acquisition
angles including the side view, with the disks parallel to
the beam is generally considered indicative of a stuck
valve. The diagnostic criteria for thrombosis on TOE were
limited leaflet motion and/or visible thrombus [32].
The low velocity of blood across the tricuspid valve pros-
thesis makes it especially prone to thrombosis. There are
well documented conditions that predispose to thrombo-
sis. Probably the commonest is a sub therapeutic INR,
with the mechanical tricuspid prosthesis requiring an INR
in the range of 3 to 4. A change to low molecular weight
heparin in place of heparin prior to surgery is yet another
common predisposing cause [33]. Hypercoagulable states
like pregnancy [34], hypereosinophilic syndromes [35],
malignancy [36], low flow states like Ebstein's anomaly
[37] and use of Biomedicus Centrifugal Pump [38], drugs
like Rifampicin, Dicloxacillin [39], HRT [40], Phenytoin
[41], mechanical rather than bioprosthetic valves [42], allJournal of Cardiothoracic Surgery 2009, 4:12 http://www.cardiothoracicsurgery.org/content/4/1/12
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predispose to a greater likelihood of developing prosthetic
valve thrombosis.
Our patient, who was continued on vancomycin and
rifampicin postoperatively, required doses of warfarin in
excess of 15 mg daily, in all probability due to the known
facilitation of the induction of warfarin degradation by
rifampicin. He presented with intermittent syncope and
profound hypoxia responsive to increasing inspired fio2.
TTE, TOE and fluoroscopy were clearly confirmatory. In
addition, contrast CT scan demonstrated secondary pul-
monary embolism and residual SVC obstruction. Clinical,
radiological and echocardiographic resolution after
Alteplase thrombolysis was instantaneous after one week
of aggressive anticoagulation failed.
Although tricuspid valve thrombosis may occasionally
respond to high intensity anticoagulation, thrombolysis
should be the first line of treatment in these patients and
is almost always successful. Failure of thrombolysis in
symptomatic patients, particularly when both leaflets are
stuck, is an indication of surgery [32] which shall usually
involve re-replacement, and rarely, thrombectomy with or
without rotation of the disk.
We believe this case report is unusual on account of the
following: 1. The fact that a perforated right atrial lead
lying more than an inch outside right atrial appendage
was discovered 13 years after the attempted unsuccessful
removal 2. Presentation of pacemaker endocarditis with a
massive load of vegetations along the entire pacemaker
lead tract in SVC, right atrial endocardium, tricuspid valve
and right ventricular endocardium, leading to a functional
and structural SVC obstruction 3. Requirement of an unu-
sually large dose of warfarin postoperatively occasioned,
in all probability, by antibiotic drug interactions 4. Pres-
entation of tricuspid prosthetic valve thrombosis
uniquely as vasovagal syncope and isolated hypoxia and
near instantaneous resolution of tricuspid prosthetic valve
thrombus with Alteplase thrombolysis.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
PK conceived, designed and drafted the manuscript and
was the principal operating surgeon and consultant in
charge of patient's care. KA and KJ assisted in the opera-
tion and collected various imaging data. WB was the pri-
mary cardiology consultant responsible for the care of the
patient. All authors revised the manuscript and made
important intellectual contributions.
Acknowledgements
Written informed consent was obtained from the patient for publication of 
this case report and the accompanying images. A copy of the written con-
sent is available for review by Editor-in Chief of the journal.
References
1. Hayes DL, Zipes DP: Cardiac pacemakers and cardioverter-
defibrillators.  In Braunwald's Heart Disease Edited by: Zipes DP,
Libby P, Bonow RO, Braunwald E. Philadelphia, Pennsylvania: Elsevier
Saunders; 2005:784. 
2. Da-Costa A, Kirkorian G, Isaaz K, Touboul P: Secondary infections
after pacemaker implantation.  Rev Med Interne 2000, 21:256-65.
3. Anguera I, Del-Rio A, Miro JM: Staphylococcus lugudensis infec-
tive endocarditis: description of 10 cases and analysis of
native valve, prosthetic valve and pacemaker lead endocar-
ditis – clinical profiles.  Heart 2005, 91:e10.
4. Laguno M, Miro O, Font C, de-la-Sierra A: Pacemaker related
endocarditis. Report of 7 cases and review of literature.  Car-
diology 1998, 90:244-8.
5. Sharma S, Tieyjeh IM, Espinosa RE, Costello BA, Baddour LM: Pace-
maker infection due to Mycobacterium fortuitum.  Scand J
Infec Dis 2005, 37:66-7.
6. Bortolotti U, Tursi V, Fasoli G, Milano A, Frigato N, Casarotto D:
Tricuspid valve endocarditis: repair with the use of tricuspid
chordee.  J Heart Valve Dis 1993, 2:567-70.
7. Klug D, Lacroix D, Savoye C, Goullard L: Systemic infection
related to endocarditis on pacemaker leads: clinical presen-
tation and management.  Circulation 1997, 95:2098-107.
8. Podolsky LA, Manginas A, Jacobs LE, Kotler MN, Ioli LW: Superior
venacaval thrombosis detected by transesophageal echocar-
diography.  J Am Soc Echocardoigr 1991, 4:189-93.
9. Nisanci Y, Yilmaz E, Oncul A, Ozsaruhan O: Predominant tricus-
pid stenosis secondary to bacterial endocarditis in a patient
with permanent pacemaker and balloon dilatation of the ste-
nosis.  Pacing Clin Electrophysiol 1999, 22:393-6.
10. Hagers Y, Koole M, Schoors D, Van Camp G: Tricuspid stenosis: a
rare complication of pacemaker related endocarditis.  J Am
Soc Echocardiogr 2000, 13:66-8.
11. Tascini C, Bongiorni MG, Gemignani G, Soldati E: Management of
cardiac device infections: A retrospective survey of a non
surgical approach combining antibiotic therapy with trans-
venous removal.  J Chemother 2006, 18:157-63.
12. Ruttman E, Hangler HB, Kilo J, Hofer D: Transvenous pacemaker
lead removal is safe and effective even in large vegetations:
an analysis of 53 cases of pacemaker lead endocarditis.  Pacing
Clin Electrophysiol 2006, 29:231-6.
13. Rundstrom H, Kennergreen C, Andersson R, Alestig K, Hogevik H:
Pacemaker endocarditis during 18 years in Goteborg.  Scand
J Infect Dis 2004, 36:674-9.
14. Cacoub P, Leprince L, Nataf P, Hausfater P, Dorent R: Pacemaker
infective endocarditis.  Am J Cardiol 1998, 82:480-4.
15. Smith HJ, Fearnot NE, Byrd CL, et al.: Five year experience with
intravascular lead extraction. US lead extraction data base.
Pacing Clin Electrophysiol 1994, 17:2016.
16. Byrd C: Management of Implant Complications.  In Clinical Car-
diac Pacing and Defibrillation Edited by: Ellenbogen KA, Kay GN,
Wilkoff BL. Philadelphia: WB Saunders; 2000:669. 
17. Byrd CL, Scwartz SJ, Hedin N: Lead extraction. Indications and
techniques.  Cardiol Clin 1992, 10:735-48.
18. Lee ME, Chaux A, Matloff JM: Avulsion of a tricuspid valve leaflet
on an infected, entrapped endocardial pacemaker electrode.
The role of electrode design.  J Thorac Cardiovasc Surg 1977,
74:433-5.
19. Meier EHK, Gray ME, John RM: Endocardial pacemaker or defi-
brillator leads with infected vegetations: a single centre
experience and consequences of transvenous extraction.  Am
Heart J 2003, 146:339-44.
20. Barbetseas J, Lalos S, Kyriakidis M, Aggeli C, Toutouzas P: Role of
transesophageal echocardiography in the diagnosis of
infected retained pacing lead.  Pacing Clin Electrophysiol 1998,
21:1159-61.
21. Victor F, DePlace C, Camus C, LeBreton H, Leclercg C, Pavin D,
Mabo P, Daubert C: Pacemaker lead infection: echocardio-
graphic features, management and outcome.  Heart 1999,
81:82-7.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Cardiothoracic Surgery 2009, 4:12 http://www.cardiothoracicsurgery.org/content/4/1/12
Page 9 of 9
(page number not for citation purposes)
22. Vransky D, Fisher V, Holoman M, Janotik P, Zajacova H: Removal of
the intravenous pacing system using the inflow occlusion
technique.  Bratisl Lek Listy 1997, 98:620-3.
23. Matsumoto Y, Akemoto K, Ushijima T, Kawakami K, Ueyama T, Sas-
aki H: Removal of infected pacemaker lead through sternot-
omy without cardiopulmonary bypass.  Jpn J Thorac Cardiovasc
Surg 1998, 46:71-4.
24. elKohen M, Milliare A, Leroy O, Beuscart C, Vanjak D, Sivery B, Sen-
neville E, Ducloux G: Infectious endocarditis of the tricuspid
valve in patients with endocardial pacemakers.  Arch Mal Coeur
Vaiss 1990, 83:1855-7.
25. Bartolotti U, Tursi V, Fasoli G, Milano A, Frigato N, Casarotto D: Tri-
cuspid valve endocarditis: repair with the use of artificial
chordae.  J Heart Valve Dis 1993, 2:567-70.
26. Leong R, Gannon BR, Childs TJ, Isotalo PA, Abdollah H: Aspergillus
fumigatus pacemaker lead endocarditis.  Can J Cardiol 2006,
22:337-40.
27. Leprince P, Nataf P, Cacoub P, Jault F, Goignard E, Bors V, Pavie A,
Cabrol C, Godeau P, Gandjbakhch I: Septicemia and endocarditis
related to transvenous pacing leads of pacemakers: surgical
indications and results.  Arch Mal Coeur Vaiss 1995, 88:241-6.
28. Hong BP, O'Toole J, Gerber ML, Moquin M, Jackson SC: Endocardi-
tis due to six entrapped pacemaker leads and concomitant
recurrent coronary atherosclerosis.  Ann Thorac Surg 1988,
46:97-9.
29. Thorburn CW, Morgan JJ, Shanahan MX, et al.: Long term results
of tricuspid valve replacement and the problem of tricuspid
valve thrombosis.  Am J Cardiol 1983, 51:1128-32.
30. Nakano K, Kayanagi H, Hashimoto A, et al.:  Tricuspid valve
replacement with St Jude Mechanical valve prosthesis.  J Tho-
rac Cardiovasc Surg 1994, 108:888-92.
31. Scully HE, Armstrong CS: Tricuspid valve replacement; 15 years
of experience with mechanical prostheses and bioprosthe-
ses.  J Thorac Cardiovasc Surg 1995, 109:1035-41.
32. Shapira Y, Sagie A, Jortner R, Adler Y, Hirsch R: Thrombosis of
bileaflet tricuspid valve prosthesis: Clinical spectrum and the
role of nonsurgical treatment.  Am Heart J 1999, 137:721-5.
33. Mahesh B, Evans S, Bryan AJ: Failure of low molecular weight
heparin in the prevention of prosthetic mitral valve throm-
bosis during pregnancy: case report and a review of options
for anticoagulation.  J Heart Valve Dis 2002, 11:745-50.
34. Hanania G, Nassivera L: Anticoagulant therapy during preg-
nancy in patients with mechanical valvular prostheses.  Arch
Mal Coeur Vaiss 2001, 94:1073-6.
35. Janoskuti L, Forhecz Z, Lengyel M: Unique presentation of hyper-
eosinophilic syndrome: recurrent mitral prosthetic valve
thrombosis without endomyocardial disease.  J Heart Valve Dis
2006, 15:726-9.
36. Aggeli C, Pitsavos C, Stefenadis C, Toutouzas P: Catastrophic
effect of the mitral prosthetic valve thrombosis in a malig-
nant case.  Int J Cardiol 2001, 80:93-4.
37. Caceras MFL, Perez HL, Santos JG, Morlans KH, Marrero AMM:
Thrombolytic treatment as first option in recurrent tricus-
pid prosthetic valve thrombosis and Ebstein's anomaly.  J
Pharm Pharm Sci 2005, 8(2):332-334.
38. Hagley MT, Lopez CA, Phillips KJ, Daily BB, Kouchoukos NT:
Thrombosis of mitral valve bioprosthesis in patients requir-
ing circulatory assistance.  Ann Thorac Surg 1995, 60:1814-6.
39. Halverson S, Husebye T, Arnesen H: Prosthetic valve thrombosis
during dicloxacillin therapy.  Scand Cardiovasc J 1999, 33:366-8.
40. Lotfi M, Hutchison SJ: Prosthetic valve thrombosis after initia-
tion of hormone replacement therapy.  Can J Cardiol 2005,
21:303-4.
41. Thrombolytic therapy of a left sided prosthetic valve throm-
bosis without hemodynamic obstruction: a case report.  J Am
Soc Echocardiogr 2001, 14:1230-4.
42. Dalrymple HMJ, Leung Y, Ohri SK, Haw MP, Ross JK, Livesey SA,
Monro JL: Tricuspid valve replacement: bioprostheses are
preferable.  J Heart Valve Dis 1999, 8:644-8.